ABC | Volume 113, Nº4, October 2019

Original Article Rodrigues et al. Myocardial strain measured by speckle tracking Arq Bras Cardiol. 2019; 113(4):737-745 19. Souza SJ, Luzia LA, Santos SS, Rondó PH. Lipid profile of HIV-infected patients in relation to antiretroviral therapy: a review. Rev Assoc Med Bras. 2013;59(2):186-98. 20. Geyer H, Caracciolo G, Abe H, Wilansky S, Carerj S, Gentile F, et al. Assessment of myocardial mechanics using speckle tracking echocardiography: fundamentals and clinical applications. J Am Soc Echocardiogr. 2010;23(4):351-69; quiz 453-5. 21.ReinschK.PrevalenceofCardiacDiastolicDysfunction inHIV-infectedPatients: Results of the HIV-HEART Study. HIV Clinical Trials. 2011;11(3):156-62. 22. Bozzette SA, Ake CF, Tam HK, Chang SW, Louis TA. Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection. N Engl J Med. 2003;348(8):702-10. 23. Starc TJ. Incidence of cardiac abnormalites in children with HIV infection: the prospective PC HIV study. J Pediatr. 2002;141(3):327-34 24. Blanco JJ, Garcia IS, Cerezo JG, Rivera JM, Anaya PM, Raya PG, et al . Endothelial function inHIV-infected patients with lowor mild cardiovascular risk. J Antimicrob Chemother. 2006; 58(1):133-9. 25. ChaparroJ,ReedsD,WenW,XuepingE,KleinS,SemenkovichC, etal .Alterations inthighsubcutaneousadiposetissuegeneexpressioninproteaseinhibitor-based highlyactiveantiretroviraltherapy.Metabolism.2005;54(5):561-7. 26. Samaras K, Wand H, Law M, Emery S, Cooper D, Carr A, et al . Prevalence of Metabolic Syndrome in HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy Using International Diabetes Foundation and Adult Treatment Panel III Criteria. Diabetes Care. 2007;30(1):113-9. 27. Currier JS, Havlir DV. Complications of HIV Disease and Antiretroviral therapy. Top HIV Medicine. 2005;13(2):70-4. 28. Sengupta PP, Krishanmoorthy VK, AbhayaratnaWP, Korinek J, BelohlavekM, Sundt TM, et al . Disparate patterns of left ventricular mechanics differentiate constrictive pericarditis from restrictive cardiomyopathy. JACC Cardiovasc Imaging. 2008;1(1):29-38. 29. Kang S, Seok H, Choi BJ, Choi SY, Hwang GS, Yoon MH, et al. Longitudinal Strain and Torsion Assessed by Two- Dimensional Speckle Tracking Correlate with the Serum Level of Tissue Inhibitor of Matrix Metalloproteinase-1, a Marker of Myocardial Fibrosis, in Patients with Hypertension. J Am Soc Echocardiogr. 2008;21(8):907-11. 30. Kosmala W, Plaksej R, Strotmann JM, Weigel C, Herrmann S, Niemann M, et al. Progression of left ventricular functional abnormalities in hypertensive patients with heart failure: An ultrasonic two dimensional speckle tracking study. Journal of the American Society of Echocardiography. J Am Soc Echocardiogr. 2008;21(12):1309-17. 31. Lipshultz SE, Wilkinson JD, Thompson B, Cheng I, Briston DA, Shearer WT, et al. Cardiac Effects of Highly Active Antiretroviral Therapy in Perinatally HIV-Infected Children: The CHAART-2 Study. J AmColl Cardiol. 2017;70(18):2240–7. 32. Francis CK. Cardiac involvement in AIDS. Curr Probl Cardiol. 1990;15(10):575-639. 33. Reynolds MM, Hecht SR, Berger M, Kolokathis A, Horowitz SF. Large pericardial effusions in the acquired immunodeficiency Syndrome. Chest. 1992;102(6):746-7. 34. Himelman RB, Chung WS, Chernoff DN, Schiller NB, Hollander H. Cardiac manifestations of human immunodeficiency virus infection: A two-dimensional echocardiographic study. J Am Coll Cardiol. 1989;13(5):1030-6. 35. Woods GL, Goldsmith JC. Fatal pericarditis due to mycobacterium aviumintracellulare in acquired immunodeficiency syndrome. Chest. 1989;95(6):1355-7. 36. Eisenberg M, Gordon AS, Schiller NB. HIV associated pericardial effusions. Chest. 1992;102(3): 956-8. 37. Stotka JL, Good CB, Downer WR, Kapoor WN. Pericardial effusion andtamponade due to Kaposi’s sarcoma in acquired immunodeficiency syndrome. Chest. 1989;95(6):1351-69. 38. Wu TC, PizzornoMC, Haywards GS, HaywardGS,Willoughby S, Neumann DA, Rose NR, et al. In situ detection of human cytomegalovirus immediate early gene transcripts within cardiac myocytes of patients with HIV- associated cardiomyopathy. AIDS. 1992;6(8):777-85. 39. Mast HL, Haller JO, Schiller MS, Anderson VM. Pericardial effusion and its relationship to cardiac disease in childrenwith acquired immunodeficiency syndrome. Pediatr Radiol. 1992;22(7):548-51. 40. Okoshi MP, Montenegro MR. Pathology of the heart in AIDS. Astudy of 73 consecutive necropsies. Arq Bras Cardiol. 1996;66(3):129-33. 41. Diógenes MS, Succi RC, Machado DM, Moisés VA, Novo FN, Carvalho AC. Estudo Cardiológico Longitudinal em Crianças Expostas ao Vírus da Imunodeficiência Humana Tipo 1 por Via Perinatal. Arq Bras Cardiol. 2005;85(4):233-40. 42. Hajjar LA, Caderaro D, Yu Pa, Giulliano I, Lima EM, Barbaro G, et al. Cardiovascular Manifestarions in Patiens Infected with the Human Immunodeficiency Virus. Arq Bras Cardiol. 2005;85(5):363-77. 43. Ntsekhe M, Hakim J. Impact of Human Immunodeficiency Virus Infection on Cardiovascular Disease in Africa. Circulation. 2005;112(23):3602-7. 744